Access Challenges for Medicare Advantage Oncology Networks Revealed by Study
Study highlights the limited access of Medicare Advantage beneficiaries to oncology networks, revealing significant disparities in cancer care availability and outcomes.
Study highlights the limited access of Medicare Advantage beneficiaries to oncology networks, revealing significant disparities in cancer care availability and outcomes.
Discover ASCO's updated 340B Drug Pricing Program policy aimed at enhancing access to oncology care for underserved populations.
Explore Shilpa Biocare's partnership with Gate2Brain targeting pediatric brain cancers, improving drug delivery, and enhancing shareholder value for the future.
Discover the latest OIG Advisory Opinion clarifying cancer detection practices and compliance. Learn valuable insights for healthcare companies on regulatory navigation.
Explore the complex insurance challenges surrounding high-cost cancer treatments like Keytruda and the legal battles patients face to access essential medications.
Explore the evolving landscape of cancer care costs and insurance regulations, revealing financial challenges in treatment access and the role of federal policies.
Discover how the new Oncology Care Model improves cancer care and enhances Medicare services through value-based approaches and quality-focused initiatives.
Discover the 2026 Harold M. Weintraub Award recipients announced by Fred Hutch Cancer Center, celebrating outstanding contributions to biological sciences.
Explore how recent advancements in cancer care impact the insurance industry, focusing on CAR T-cell therapy and regulatory compliance.
Explore the complexities of prior authorizations in health insurance, emphasizing coordination among providers and the need for timely updates in medical guidelines.